Navigation Links
New Paper Reveals Reasons for Payer Discontent with Disease Management
Date:9/8/2008

A thought provoking manuscript addressing key challenges facing the industry.

Nashville, TN (PRWEB) September 8, 2008 -- From pioneering research and profound insight into the inner workings of disease management (DM) comes a thought provoking manuscript addressing key challenges facing the industry. The article is published this month in The Journal of Managed Care Pharmacy.

http://www.amcp.org/data/jmcp/643-649_8055-Final.pdf [Why 2008 May Be The Tipping Point for Disease Management], by disease management research expert Brenda Motheral, BPharm, MBA, PhD, presents a compelling view on why 2008 has been a year of discontent in the disease management industry but could actually pave the way for new business models and competitors.

In the paper, Dr. Motheral explains: "While once the darling of employers and benefit consultants, disease management is now the object of considerable dissatisfaction and growing distrust. Based on industry observation, there seem to be multiple reasons for this disaffection, five of which include lack of: 1) alignment of vendor and client interests, 2) transparency in business arrangements; 3) plausibility in reports of financial and clinical outcomes; 4) rigorous evaluation methodology; and 5) convincing evidence of outcomes improvement."

The goal of this candid commentary is to draw attention to the DM industry's deficiencies while clearly stating that there are short- and long-term solutions to be considered. Here are a few examples outlined in the paper:

  • If still using an opt-out model with limited transparency, plan sponsors can move to an engagement revenue model and require greater detail on engagement and interventions, including call recording.
  • Expand outcome assessments beyond methodologically-weak financial ROIs to include more frequent reporting of key leading clinical indicators that are less susceptible to exaggeration, such as medical compliance.

According to Dr. Motheral: "In today's economy, plan sponsors can no longer afford to purchase disease management services on faith, and without greater evidence of value. To be successful, the new generation of disease management vendors must be much more methodical in determining which individuals to target, how much intervention is really warranted and how to provide customized solutions to address the most important needs of each plan sponsor," .

About CareScientific
Led by Dr. Brenda Motheral, CareScientific is a trusted consulting resource developed to improve the efficiency and effectiveness of disease management, health, wellness and pharmaceutical care programs. To learn more, please visit www.CareScientific.com.

Contact:
Kate Leach
Marketing Communications Consultant
The Agency
575.937.8423
kate @ itstheagency.com

# # #

Read the full story at http://www.prweb.com/releases/2008/09/prweb1303304.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. USA TODAY Continues Spirit of the USA Charity Program as Part of Newspapers 25th Anniversary Celebration
2. USA TODAY Concludes Spirit of the USA Charity Program as Part of Newspapers 25th Anniversary Celebration
3. 454 Sequencing(TM): Science Paper Describes a Novel, Highly Efficient Method of Sequencing Ancient DNA; Sequences the Mitochondria of 10 Individual Mammoths to Prove It
4. New RAPS White Paper Details Career Development of Healthcare Products Regulatory Professionals
5. APC papers in global theme issue on poverty
6. Lost in the middle: author order matters, new paper says
7. Free White Paper Details Hospital Strategies for Meeting Joint Commission Compliance Requirements in the Environment of Care
8. MediNotes EMR Now Interfaces With 76 Practice Management Systems, Allowing More Medical Practices to Replace Their Patients Aging Paper Medical Records
9. Free White Paper From The Beryl Institute Quantifies Bottom-Line Impact of Corporate Culture
10. White Paper Details How to Choose the Right EMS Provider for Medical Products Outsourcing
11. Thomson Scientific Takes a Fresh Look at Multiauthor Papers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... ... Maury Regional Health has announced a large-scale adoption of AccuVein vein visualization ... Regional Medical Center is making vein visualization part of their standard of care. , ... importantly, helps our staff members locate a vein that will provide good access to ...
(Date:8/16/2017)... ... August 16, 2017 , ... A global leader in the treatment ... clinics in all 29 Indian states—bringing the country one step closer to eliminating clubfoot ... the nonprofit organization is on track to enroll 10,000 children in the clubfoot treatment ...
(Date:8/16/2017)... ... , ... Fusion Flix Inc., a Telly Award Winning, Non Profit Corporation has ... viewers in a partnership with the Amazon Video Direct Streaming Distribution Platform. , Their ... Ray disc in 2018. Proceeds will be going to further health research. , ...
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... TopConsumerReviews.com recently ... Lab Testing . , The healthcare industry in the United States has undergone ... are the days of needing to have a doctor’s order to get a blood ...
(Date:8/16/2017)... , ... August 16, 2017 , ... First Choice ... States, named Dr. Douglas J. Harrison, as the new Medical Director of its Sienna ... new facility Medical Director of our Sienna Plantation location,” said Dr. Michael (Derek) Caraway, ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... , Aug. 15, 2017  AOTI Inc. announced today that its ... Inc., has recently opened a New York City Office in ... of its unique Topical Wound Oxygen (TWO 2 ) homecare therapy. ... Accreditation Commission for Health Care (ACHC) under the company,s DMEPOS accreditation ... ...
(Date:8/8/2017)... Israel, Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), ... today reports its financial results for the second quarter ... during the second quarter 2017 and to date: ... clinical development programs for the Company,s lead project, BL-8040: ... pivotal study with BL-8040 as novel stem cell mobilization ...
(Date:8/7/2017)... Mich. , Aug. 7, 2017 Diplomat Pharmacy, ... of Joel Saban as president, effective Aug. 7, ... Urick has decided to pursue other interests and will ... "During his tenure, Paul has served us in multiple leadership ... Specialty Pharmacy in Jun. 2015 and has provided decisive, strategic ...
Breaking Medicine Technology: